-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- Finch Therapeutics Group, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$6.11M, a 38.2% increase year-over-year.
- Finch Therapeutics Group, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.5M, a 86.5% increase year-over-year.
- Finch Therapeutics Group, Inc. annual Operating Income (Loss) for 2023 was -$83.9M, a 27.5% increase from 2022.
- Finch Therapeutics Group, Inc. annual Operating Income (Loss) for 2022 was -$116M, a 92.7% decline from 2021.
- Finch Therapeutics Group, Inc. annual Operating Income (Loss) for 2021 was -$60M, a 52.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)